BGB-A317_Study_001
Completed
Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors
BeOne Study ID 
BGB-A317_Study_001
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex:
All
Age: 18 Years / N/A